期刊文献+

化疗药物所致神经毒性的机制及治疗进展 被引量:6

Research Progress in Mechanism of Chemotherapy-induced Neurotoxicity and its Treatment
原文传递
导出
摘要 化疗药物所致神经毒性是化疗副反应中仅次于血液系统毒性的常见副反应,成为限制化疗药物使用剂量、影响疗效的主要因素。全文从常见化疗药物神经毒性的症状、致病机制和治疗策略等方面进行阐述。
作者 纪文翔 褚倩
出处 《中国肿瘤》 CAS 2012年第5期354-357,共4页 China Cancer
  • 相关文献

参考文献20

  • 1Alaedini A, Xiang Z, Kim H, et al. Up-regulation of apop- tosis and regeneration genes in the dorsal root ganglia during cisplatin treatment [J]. Exp Neurol, 2008, 210(2): 368-374.
  • 2Grolleau F, Gamelin L, Boisdron-Celle M, et al. A possi- ble explanation for a neurotoxic effect of the anticancer a- gent oxaliplatin on neuronal voltage-gated sodium chan- nels[J]. J Neurophysiol, 2001, 85(5): 2293-2297.
  • 3Webster RG, Brain KL, Wilson RH, et al. Oxaliplatin in- duces hyperexcitability at motor and autonomic neuromus- cular junctions through effects on voltage-gated sodium channels[J]. Br J Pharmacol, 2005, 146(7): 1027-1039.
  • 4Takimoto CH, Remick SC, Sharma S, et al. Dose-escalat- ing and pharmacological study of oxaliplatin in adult can- cer patients with impaired renal function: a National Can- cer Institute Organ Dysfunction Working Group Study[J]. J Clin Oncol, 2003, 21(14): 2664-2667.
  • 5Cavaletti G, Tredici G, Petruccioli MG, et al. Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat [J]. Eur J Cancer, 2001, 37(18): 2457-2463.
  • 6Flatters SJ, Bennett GJ. Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropa- thy: evidence for mitochondrial dysfunction[J]. Pain, 2006, 122(3): 247-257.
  • 7Xiao W, Boroujerdi A, Bennett GJ, et al. Chemotherapy- evoked painful peripheral neuropathy: analgesic effects of gabapentin and effects on expression of the alpha-2-delta type-1 calcium channel subunit [J]. Neuroscience, 2007, 144(2): 714-720.
  • 8Lecomte T, Landi B, Beaune P, et al. Glutathione S-trans- ferase P1 polymorphism (Ilel05Val) predicts cumulative neuropathy in patients receiving oxaliplatin-based chemotherapy [J]. Clin Cancer Res, 2006, 12 (10): 3050- 3056.
  • 9Ruzzo A, Graziano F, Loupakis F, et al. Pharmacogenetic profi ling in patients with advanced colorectal cancer treated with first-line FOLFOX-4 chemotherapy [J]. J Clin Oncol, 2007, 25(10): 1247-1254.
  • 10McLeod HL, Sargent D J, Marsh S, et al. Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North Ameri- can Gastrointestinal Intergroup Trial N9741[J]. J Clin On- col, 2010, 28(20): 3227-3233.

同被引文献86

引证文献6

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部